what is peptide sequence of mage 1 protein sequences - they-can-combine-via-peptide-bonds-to-make-a-protein ITKKVADLVGF Unraveling the Peptide Sequence of MAGE-1 Protein: A Key to Cancer Immunotherapy

theramid-peptides The MAGE-1 protein, a member of the MAGE gene family, plays a significant role in oncology due to its expression in various tumor types, including melanoma, head and neck squamous cell carcinoma, lung carcinoma, and breast carcinomaIdentification of the MAGE-1 gene product by monoclonal .... A critical aspect of understanding MAGE-1's function and its potential as a therapeutic target lies in deciphering its peptide sequence.MAGE-1 (102-112) - Peptides This exploration delves into the known peptide sequences derived from the MAGE-1 protein, their significance in the context of cytolytic T lymphocytes (CTLs), and their implications for cancer vaccination and immunotherapyMAGE-A1 (278-286) peptide - KVLEYVIKV.

MAGE proteins are characterized by highly conserved MAGE homology domains (MHDs) and are recognized as cancer-testis antigens (CTAs).作者：Y AKIYAMA·2009·被引用次数：12—TCR cDNAsequencesinMAGE-1A24peptide-specific CTLs. Two clones ofMAGE-1A24peptide-specific TCR cDNAsequencesare shown in Figure 6 (sequenceA and B). This means they are typically expressed in normal adult cells only in male germ-line cells, while being aberrantly expressed in a wide range of human tumors. This tumor-specific expression makes MAGE proteins attractive targets for the immune system and for the development of novel cancer therapies.Identification of the MAGE-1 gene product by monoclonal ...

The immunogenicity of MAGE-1 arises from its ability to be processed by tumor cells and presented on major histocompatibility complex (MHC) class I molecules, such as HLA-A1, as determinants for cytolytic T lymphocytes (CTLs). These CTLs can then recognize and eliminate cancer cells expressing these MAGE-1 peptidesA New MAGE Gene with Ubiquitous Expression Does Not .... Identifying the precise peptide sequences that elicit such immune responses is crucial for developing effective immunotherapies.

Several studies have identified specific MAGE-1 peptide sequences recognized by immune cells. For instance, a peptide sequence corresponding to positions 102–112 of the MAGE-1 protein sequence has been identified as ITKKVADLVGFAntigen binding proteins specifically binding mage-a. This particular peptide sequence has been shown to be recognized by CTLs.Cloning and Analysis of MAGE-1-Related Genes Another significant finding is the MAGE-A1 (278-286) peptide, with the sequence KVLEYVIKV. This nonapeptide has a molecular weight of approximately 1090.36 g/mol and a purity typically exceeding 95%.The antigenicpeptideof MZ2-D is a nonapeptide that is encoded by thesequence of MAGE-3 that is homologous to theMAGE-1 sequencecoding for the MZ2-Epeptide...

Furthermore, research has identified other MAGE-1 derived peptides. The MAGE-1 (161-169) peptide sequence is notable as the first MAGE CTL epitope mapped and is restricted by HLA-A1. Human melanoma cells can process the MAGE-1 gene product and present it on their MHC class I molecules as a determinant for CTLs. Another identified peptide sequence is SESIKKKVL, from the MAGE-1 (102-112) region, which has demonstrated efficient killing of HLA-A2 tumor cells expressing this peptidePepTivator MAGE-A1 is a pool of lyophilized peptides, consisting mainly of15-mer sequenceswith 11 amino acids overlap, covering the complete sequence of the ....

The MAGE-A1 gene family also yields other immunogenic peptides. For example, the MAGE-A1 (96-104) peptide sequence has been shown to be immunogenicA number of genes of theMAGEfamily have been shown to code for antigens that are recognized on many human tumors by autologous CTLs. These antigens should be strictly tumor specific because the encodingMAGEgenes are not expressed in normal adult cells, except for male germ-line cells, which lack HLA expression.. Additionally, a peptide sequence designated H-EADPTGHSY-OH has been characterized as an Antigen Peptide MAGE-A1 HLA-A*0101.Mage-1 Antigen (161-169),human CAS NO.144449-86-5 This peptide is typically supplied in a lyophilized form with a purity of over 90% (HPLC/MS)作者：P Chaux·2001·被引用次数：38—It contains one third of thesequenceof the Haemophilus influenzae Lipo Dproteinat its N-terminal extremity, the entire codingsequence of MAGE-1and a C- ....

Beyond these specific sequences, PepTivator® MAGE-A1, human represents a pool of lyophilized peptides, primarily consisting of 15-mer sequences with an 11 amino acid overlap, designed to cover the complete sequence of the MAGE-A1 protein. This comprehensive approach aims to capture a broader range of T cell epitopes.

The identification and synthesis of these MAGE-1 peptide sequences are fundamental for advancing cancer immunotherapy. They form the basis for developing peptide-based cancer vaccines, where specific peptide sequences are administered to patients to stimulate an anti-tumor immune response.PepTivator MAGE-A1 is a pool of lyophilized peptides, consisting mainly of15-mer sequenceswith 11 amino acids overlap, covering the complete sequence of the ... The ability to synthesize these peptides with high purity, such as through methods involving free N-terminal acetylation and C-terminal amidation for modified peptides, ensures their efficacy and safetyThe antigenicpeptideof MZ2-D is a nonapeptide that is encoded by thesequence of MAGE-3 that is homologous to theMAGE-1 sequencecoding for the MZ2-Epeptide....

The study of MAGE proteins and their peptide sequences is an ongoing field of research. Understanding the precise protein sequence and how it is processed into immunogenic peptides is vital for personalized medicine approaches in cancer treatment. The development of MAGE-A1-derived peptide acetate and other synthetic peptide antigens highlights the continuous innovation in this area, aiming to harness the power of the immune system against cancer. The detailed analysis of peptide sequences and their interaction with MHC molecules, such as HLA-A24 with the MAGE-1A24 peptide, provides invaluable insights into the mechanisms of anti-tumor immunity. The commitment to understanding the sequences of MAGE proteins and their associated peptides underscores their potential to revolutionize cancer care.